Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis.
Eleni S VasileiouChen HuCharles N BernsteinFred LublinJerry S WolinskyGary R CutterElias S SotirchosKaarina KowalecSalter AmberShiv SaidhaEllen M MowryPeter A CalabresiRuth Ann MarrieKathryn C FitzgeraldPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
Genetically determined lower 25(OH)D levels were not associated with worse disease outcomes in PwMS and raises questions about the plausibility of a treatment effect of vitamin D in established MS.